Anti-tumor necrosis factor (TNF)-α monoclonal antibodies are a class of drugs widely used in the treatment of autoimmune and inflammatory dermatological diseases, such as psoriasis, hidradenitis suppurativa as an off-label therapy, in BP, and pemphigus vulgaris (PV). This evidence concerns the gene TNF and hidradenitis suppurativa.